alexa Abstract | Methylated Sept9 Gene is a Sensitive Biomarker for all Stages of Colorectal Cancer

Colorectal Cancer: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


The SEPT9 gene methylation assay has been proved to be a reliable assay for CRC detection by many studies. Due to the highly sensitive properties of the assay, analysis of quantitative data is crucial for qualitative interpretation of the test results. However, different analysis methods used currently in data interpretation led to variation in test sensitivity and may affect the test effectiveness in CRC detection. Here we review the methods used in data interpretation in major clinical trials performed so far, and provide our recommendations for data interpretation in future practice.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Lele Song Yuemin Li


Septin 9, SEPT9, Septin, Methylation, Colorectal cancer, Adenoma, FOBT, FIT, Colorectal Surgery, Benign Colorectal Disease, Crohns Disease

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us